IMRN
Price
$1.78
Change
-$0.02 (-1.11%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
9.37M
52 days until earnings call
PHIO
Price
$1.07
Change
-$0.10 (-8.55%)
Updated
Apr 4, 04:58 PM (EDT)
Capitalization
5.54M
Ad is loading...

IMRN vs PHIO

Header iconIMRN vs PHIO Comparison
Open Charts IMRN vs PHIOBanner chart's image
Immuron
Price$1.78
Change-$0.02 (-1.11%)
Volume$100
Capitalization9.37M
Phio Pharmaceuticals
Price$1.07
Change-$0.10 (-8.55%)
Volume$100
Capitalization5.54M
IMRN vs PHIO Comparison Chart
Loading...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRN vs. PHIO commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRN is a Hold and PHIO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 06, 2025
Stock price -- (IMRN: $1.80 vs. PHIO: $1.17)
Brand notoriety: IMRN and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRN: 439% vs. PHIO: 20%
Market capitalization -- IMRN: $9.37M vs. PHIO: $5.54M
IMRN [@Biotechnology] is valued at $9.37M. PHIO’s [@Biotechnology] market capitalization is $5.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRN’s FA Score shows that 1 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • IMRN’s FA Score: 1 green, 4 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, IMRN is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRN’s TA Score shows that 2 TA indicator(s) are bullish while PHIO’s TA Score has 5 bullish TA indicator(s).

  • IMRN’s TA Score: 2 bullish, 2 bearish.
  • PHIO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PHIO is a better buy in the short-term than IMRN.

Price Growth

IMRN (@Biotechnology) experienced а 0.00% price change this week, while PHIO (@Biotechnology) price change was -10.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

IMRN is expected to report earnings on May 28, 2025.

PHIO is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMRN($9.37M) has a higher market cap than PHIO($5.54M). IMRN YTD gains are higher at: 5.882 vs. PHIO (-35.000). IMRN (-7.35M) and PHIO (-7.41M) have comparable annual earnings (EBITDA) . IMRN has more cash in the bank: 7.74M vs. PHIO (5.39M). IMRN has higher revenues than PHIO: IMRN (6.54M) vs PHIO (0).
IMRNPHIOIMRN / PHIO
Capitalization9.37M5.54M169%
EBITDA-7.35M-7.41M99%
Gain YTD5.882-35.000-17%
P/E RatioN/A0.01-
Revenue6.54M0-
Total Cash7.74M5.39M144%
Total DebtN/A0-
FUNDAMENTALS RATINGS
IMRN vs PHIO: Fundamental Ratings
IMRN
PHIO
OUTLOOK RATING
1..100
139
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
6391
P/E GROWTH RATING
1..100
10058
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMRN's Valuation (30) in the Biotechnology industry is somewhat better than the same rating for PHIO (65). This means that IMRN’s stock grew somewhat faster than PHIO’s over the last 12 months.

IMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PHIO (100). This means that IMRN’s stock grew similarly to PHIO’s over the last 12 months.

IMRN's SMR Rating (97) in the Biotechnology industry is in the same range as PHIO (98). This means that IMRN’s stock grew similarly to PHIO’s over the last 12 months.

IMRN's Price Growth Rating (63) in the Biotechnology industry is in the same range as PHIO (91). This means that IMRN’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's P/E Growth Rating (58) in the Biotechnology industry is somewhat better than the same rating for IMRN (100). This means that PHIO’s stock grew somewhat faster than IMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMRNPHIO
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
89%
Stochastic
ODDS (%)
Bullish Trend about 1 month ago
90%
Bullish Trend 5 days ago
88%
Momentum
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend about 1 month ago
88%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend about 1 month ago
86%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend about 1 month ago
89%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend about 1 month ago
90%
Bullish Trend 5 days ago
83%
Aroon
ODDS (%)
Bearish Trend about 1 month ago
88%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Ad is loading...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

IMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRN has been closely correlated with RIGL. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMRN jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRN
1D Price
Change %
IMRN100%
+2.86%
RIGL - IMRN
82%
Closely correlated
-3.05%
CLNN - IMRN
80%
Closely correlated
+1.67%
HOOK - IMRN
79%
Closely correlated
-7.22%
AZTR - IMRN
72%
Closely correlated
-1.48%
PHIO - IMRN
72%
Closely correlated
-3.31%
More

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been closely correlated with RIGL. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if PHIO jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
-3.31%
RIGL - PHIO
84%
Closely correlated
-3.05%
CLNN - PHIO
83%
Closely correlated
+1.67%
HOOK - PHIO
81%
Closely correlated
-7.22%
DARE - PHIO
81%
Closely correlated
+0.69%
IMRN - PHIO
71%
Closely correlated
+2.86%
More